NEW YORK, May 4, 2011 /PRNewswire/ — Robotic
prostatectomy and prostate cancer
treatment expert Dr. David B. Samadi, Vice Chairman, Department
of Urology, and Chief of Robotics and Minimally Invasive Surgery at
The Mount Sinai Medical Center in New York City, appeared on
FOX-NY’s Good Day New York to discuss the successes of robotic
surgery in prostate
cancer treatment, and the benefits it has over other treatment
options, making robotic
surgery a preferential method for prostate
cancer treatment.
(Photo: http://photos.prnewswire.com/prnh/20110504/NY95457)
When choosing a robotic prostatectomy as a first line of defense
against organ confined prostate cancer, the odds of a cancer cure
with minimal post operative complications are in the patient’s
favor, according to data gathered from Mount Sinai’s robotic
surgery program.
In the event of the recurrence of cancer, radiation can then be
used as an additional tool to treat the patient. “If a
patient is first treated with radiation, and the prostate cancer
returns, it’s extremely difficult to follow-up with a successful
prostate surgery, known as a salvage robotic prostatectomy, unless
the surgeon is very skilled in the technique. The incidences
of incontinence, as well as impotence, are extremely high after
prostate surgery under this scenario. I see low dose
radiation as a supplemental tool to robotic surgery. It’s
useful in treating recurring cancer after a prostatectomy, which is
unlikely to occur based on my surgical experience, particularly
with the SMART Surgery Technique,” said Samadi.
SOURCE
